Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Nebraska Women Benefit From Efforts To Close Gaps In Cancer Screening
http://www.medicalnewstoday.com/articles/118425.php
A decade-long Nebraska study that showed disparities in breast and cervical cancer screenings could have spurred changes that raised the percentage of women screened in the state."Disparities in screening between racial and ethnic groups, even in a homogeneous state such as Nebraska, are a problem and by digging into some of the differences we were able to have an impact on breast and cervical cancer screening," said lead study author Shingairai Feresu, Ph.
----------------------------------------------
** CANCER / ONCOLOGY News **
Cancer Signatures Uncovered
http://www.medicalnewstoday.com/articles/118428.php
A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.
CTI Announces That The EORTC Completes Enrollment In Phase II Clinical Trial Of Brostallicin
http://www.medicalnewstoday.com/articles/118393.php
Cell Therapeutics, Inc.'s (CTI) (NASDAQ and MTA: CTIC) subsidiary Systems Medicine (SM) has announced that planned enrollment is complete in the European Organization for Research and Treatment of Cancer (EORTC) randomized phase II clinical trial of brostallicin in patients with newly diagnosed advanced or metastatic soft tissue sarcoma who have had no prior chemotherapy.
Rheb's Role In Cancer
http://www.medicalnewstoday.com/articles/118383.php
Two independent papers in the August 15th issue of <i>G&D</i> identify the Rheb GTPase as a novel oncogene and a promising new chemotherapeutic target.The first paper, from Dr. Pier Paolo Pandolfi (BIDMC and Harvard Medical School) and colleagues, demonstrates that the Ras-like small GTPase, Rheb, is directly involved in prostate tumorigenesis.
Prototype Test For Predicting Clinical Outcome For Melanoma Patients - Gene Signature Prognostication Of Rapid Progression From Stage III To Stage IV
http://www.medicalnewstoday.com/articles/118347.php
Investigators from the Melbourne Center of the international Ludwig Institute for Cancer Research (LICR) and Pacific Edge Biotchnology Ltd today reported that they have developed a test to predict whether a patient will progress rapidly from Stage III melanoma to metastatic Stage IV cancer and death.
Nanotubes Deliver High-potency Punch To Cancer Tumors In Mice By Slipping Through Cell Walls
http://www.medicalnewstoday.com/articles/118335.php
The problem with using a shotgun to kill a housefly is that even if you get the pest, you'll likely do a lot of damage to your home in the process. Hence the value of the more surgical flyswatter.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Inhibitors Of The Molecule PI3K Throw One Form Of Leukemia A CurveB-ALL
http://www.medicalnewstoday.com/articles/118388.php
Some cases of a form of leukemia known as pre-B cell acute lymphoblastic leukemia (pre-B-ALL) are caused by a genetic event that leads to the generation of a rogue chromosome known as the Philadelphia (Ph) chomosome, and individuals with Ph+ pre-B-ALL tend to have a poor outlook.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Comparing Intermittent To Continuous Androgen Deprivation For Advanced Prostate Cancer
http://www.medicalnewstoday.com/articles/118333.php
UroToday.com - Dr. Arto Salonen and Finnish colleagues compared intermittent androgen deprivation (IAD) to continuous androgen deprivation (CAD) in 856 patients with locally advanced or metastatic prostate cancer (CaP) treated at 27 clinics in Finland.
Health Risk Behaviors And Prostate Specific Antigen Awareness Among Men In California
http://www.medicalnewstoday.com/articles/118332.php
UroToday.com - In the August 2008 issue of the Journal of Urology, Dr. Firas Ahmed and associates investigated the correlation between certain health risk behaviors and awareness of the PSA test among men residing in California.
Risk Of Prostate Cancer After Diagnosis Of Atypical Glands Suspicious For Carcinoma On Saturation And Traditional Biopsies
http://www.medicalnewstoday.com/articles/118331.php
UroToday.com - In the September 2008 issue of the Journal of Urology, Dr. Robert Abouassaly and associates from the Cleveland Clinic reported that the finding of atypia on prostate biopsy is associated with a high likelihood of underlying malignancy, regardless of the number of cores taken at the initial biopsy.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment